Etoxeridine

Etoxeridine
Clinical data
Other names	Etoxeridine, Carbetidine, Atenos
ATC code	none;
Legal status
Legal status	AU: S9 (Prohibited substance); BR: Class A1 (Narcotic drugs); CA: Schedule I; DE: Anlage I (Authorized scientific use only); UK: Class A; US: Schedule I;
Identifiers
	IUPAC name Ethyl 1-[2-(2-hydroxyethoxy)ethyl]-4-phenylpiperidine-4-carboxylate;
CAS Number	469-82-9 ;
PubChem CID	61122;
DrugBank	DB01505 ;
ChemSpider	55070 ;
UNII	RHW35E1G7E;
KEGG	D12680 ;
ChEMBL	ChEMBL2104254;
CompTox Dashboard (EPA)	DTXSID30196980 ;
ECHA InfoCard	100.006.750
Chemical and physical data
Formula	C18H27NO4
Molar mass	321.417 g·mol−1
3D model (JSmol)	Interactive image;
	SMILES C1(CCN(CC1)CCOCCO)(C(=O)OCC)C2=CC=CC=C2;
	InChI InChI=1S/C18H27NO4/c1-2-23-17(21)18(16-6-4-3-5-7-16)8-10-19(11-9-18)12-14-22-15-13-20/h3-7,20H,2,8-15H2,1H3 ; Key:KJTKYGFGPQSRRA-UHFFFAOYSA-N ;
	(verify)

Etoxeridine (Carbetidine, Atenos) is a 4-phenyl piperidine derivative that is related to the clinically used opioid analgesic drug pethidine (meperidine).

Etoxeridine was developed in the 1950s and investigated for use in surgical anesthesia, however it was never commercialized and is not currently used in medicine. As with other opioids which were not in clinical use during the drafting of the Controlled Substances Act, it is categorized as a Schedule I narcotic.

This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.